Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Int J Mol Sci
2023 Apr 01;247:. doi: 10.3390/ijms24076591.
Show Gene links
Show Anatomy links
Use of Nanostructured Silica SBA-15 as an Oral Vaccine Adjuvant to Control Mycoplasma hyopneumoniae in Swine Production.
Storino GY
,
Petri FAM
,
Mechler-Dreibi ML
,
Aguiar GA
,
Toledo LT
,
Arruda LP
,
Malcher CS
,
Martins TS
,
Montassier HJ
,
Sant'Anna OA
,
Fantini MCA
,
de Oliveira LG
.
???displayArticle.abstract???
Mycoplasma hyopneumoniae is a difficult-to-control bacterium since commercial vaccines do not prevent colonization and excretion. The present study aimed to evaluate the performance of an orally administered vaccine composed of antigens extracted from Mycoplasma hyopneumoniae and incorporated into mesoporous silica (SBA-15), which has an adjuvant-carrier function, aiming to potentiate the action of the commercial intramuscular vaccine. A total of 60 piglets were divided into four groups (n = 15) submitted to different vaccination protocols as follows, Group 1: oral SBA15 + commercial vaccine at 24 days after weaning, G2: oral vaccine on the third day of life + vaccine commercial vaccine at 24 days, G3: commercial vaccine at 24 days, and G4: commercial vaccine + oral vaccine at 24 days. On the first day, the piglets were weighed and, from the third day onwards, submitted to blood collections for the detection and quantification of anti-Mycoplasma hyopneumoniae IgG. Nasal swabs were collected to monitor IgA by ELISA, and oropharyngeal swabs were used to assess the bacterial load by qPCR. Biological samples were collected periodically from the third day of life until the 73rd day. At 41 days of life, 15 individuals of the same age, experimentally challenged with an inoculum containing M. hyopneumoniae, were co-housed with the animals from groups (1 to 4) in a single pen to increase the infection pressure during the nursery period. At 73 days, all piglets were euthanized, and lungs were evaluated by collecting samples for estimation of bacterial load by qPCR. Quantitative data obtained from physical parameters and laboratory investigation were analyzed by performing parametric or non-parametric statistical tests. Results indicate that animals from G2 showed smaller affected lung areas compared to G3. Animals from G2 and G4 had a low prevalence of animals shedding M. hyopneumoniae at 61 days of age. Additionally, no correlation was observed between lung lesions and M. hyopneumoniae load in lung and BALF samples in animals that received the oral vaccine, while a strong correlation was observed in other groups. In the present study, evidence points to the effectiveness of the oral vaccine developed for controlling M. hyopneumoniae in pig production under field conditions.
140495/2019-3 National Council for Scientific and Technological Development, 2021/11914-0 São Paulo Research Foundation, 2020/05198-7 São Paulo Research Foundation
Allen,
Treatment, promotion, commotion: antibiotic alternatives in food-producing animals.
2013,
Pubmed
Almeida,
Cytokine expression and Mycoplasma hyopneumoniae burden in the development of lung lesions in experimentally inoculated pigs.
2020,
Pubmed
Bandrick,
Maternal immunity enhances Mycoplasma hyopneumoniae vaccination induced cell-mediated immune responses in piglets.
2014,
Pubmed
Birkenheuer,
Development and evaluation of a seminested PCR for detection and differentiation of Babesia gibsoni (Asian genotype) and B. canis DNA in canine blood samples.
2003,
Pubmed
Bustin,
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.
2009,
Pubmed
Chae,
Porcine respiratory disease complex: Interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae.
2016,
Pubmed
Devillers,
Variability of colostrum yield and colostrum intake in pigs.
2007,
Pubmed
Duarte,
Intestinal microbiota and its interaction to intestinal health in nursery pigs.
2022,
Pubmed
Ellis,
How well do vaccines for Bordetella bronchiseptica work in dogs? A critical review of the literature 1977-2014.
2015,
Pubmed
Ferraz,
Lung consolidation caused by Mycoplasma hyopneumoniae has a negative effect on productive performance and economic revenue in finishing pigs.
2020,
Pubmed
Fourour,
A new multiplex real-time TaqMan® PCR for quantification of Mycoplasma hyopneumoniae, M. hyorhinis and M. flocculare: exploratory epidemiological investigations to research mycoplasmal association in enzootic pneumonia-like lesions in slaughtered pigs.
2018,
Pubmed
Garcia-Morante,
Assessment of Mycoplasma hyopneumoniae-induced Pneumonia using Different Lung Lesion Scoring Systems: a Comparative Review.
2016,
Pubmed
Hyland,
Oral immunization induces local and distant mucosal immunity in swine.
2004,
Pubmed
Joyce,
Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats.
2018,
Pubmed
Lin,
Protective effects of oral microencapsulated Mycoplasma hyopneumoniae vaccine prepared by co-spray drying method.
2003,
Pubmed
Maes,
Update on Mycoplasma hyopneumoniae infections in pigs: Knowledge gaps for improved disease control.
2018,
Pubmed
Mechler-Dreibi,
Oral vaccination of piglets against Mycoplasma hyopneumoniae using silica SBA-15 as an adjuvant effectively reduced consolidation lung lesions at slaughter.
2021,
Pubmed
Mercuri,
Ordered mesoporous silica SBA-15: a new effective adjuvant to induce antibody response.
2006,
Pubmed
Murtaugh,
Advances in swine immunology help move vaccine technology forward.
2014,
Pubmed
Poonsuk,
Historical and contemporary aspects of maternal immunity in swine.
2018,
Pubmed
Rasmussen,
3D visualisation of hepatitis B vaccine in the oral delivery vehicle SBA-15.
2019,
Pubmed
Scaramuzzi,
Nanostructured SBA-15 silica as an adjuvant in immunizations with hepatitis B vaccine.
2011,
Pubmed
Sheldon,
The use and interpretation of the Friedman test in the analysis of ordinal-scale data in repeated measures designs.
1996,
Pubmed
Sibila,
Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection.
2009,
Pubmed
Simionatto,
Mycoplasma hyopneumoniae: from disease to vaccine development.
2013,
Pubmed
Stinson,
Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.
2016,
Pubmed
Vicca,
Evaluation of virulence of Mycoplasma hyopneumoniae field isolates.
2003,
Pubmed
Wilson,
Evidence for a common mucosal immune system in the pig.
2015,
Pubmed